178 related articles for article (PubMed ID: 28625615)
1. Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
Marciniak C; McAllister P; Walker H; Brashear A; Edgley S; Deltombe T; Khatkova S; Banach M; Gul F; Vilain C; Picaut P; Grandoulier AS; Gracies JM;
PM R; 2017 Dec; 9(12):1181-1190. PubMed ID: 28625615
[TBL] [Abstract][Full Text] [Related]
2. Real-world differences in dosing and clinical utilization of OnabotulinumtoxinA and AbobotulinumtoxinA in the treatment of upper limb spasticity.
Bohart Z; Dashtipour K; Kim H; Schwartz M; Zuzek A; Singh R; Nelson M
Toxicon; 2024 Apr; 241():107678. PubMed ID: 38447766
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Double-Blind, Active Control, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Liztox
Ye DH; Chun MH; Park YG; Paik NJ; Lee SU; Yoo SD; Kim DY
Toxins (Basel); 2023 Dec; 15(12):. PubMed ID: 38133201
[TBL] [Abstract][Full Text] [Related]
4. Effect of early use of AbobotulinumtoxinA after stroke on spasticity progression: Protocol for a randomised controlled pilot study in adult subjects with moderate to severe upper limb spasticity (ONTIME pilot).
Kong KH; Balcaitiene J; Berard H; Maisonobe P; Goh KJ; Kumthornthip W; Rosales RL
Contemp Clin Trials Commun; 2017 Jun; 6():9-16. PubMed ID: 29740633
[TBL] [Abstract][Full Text] [Related]
5. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
Săndulescu MI; Cinteză D; Poenaru D; Potcovaru CG; Păunescu H; Coman OA
Toxins (Basel); 2024 Mar; 16(4):. PubMed ID: 38668597
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Extracorporeal Shock Wave Therapy after Botulinum Toxin Injection for Post-Stroke Upper Extremity Spasticity: A Randomized Controlled Study.
Lee J; Yang SN
Toxins (Basel); 2024 Apr; 16(4):. PubMed ID: 38668622
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Enhancement of Botulinum Toxin Injections for Post-Stroke Spasticity by Use of Stretching Exercises-A Randomized Controlled Trial.
Hwang IS; Ryu JW; Jin S; Kim SA; Kim MS
Toxins (Basel); 2024 Jun; 16(6):. PubMed ID: 38922161
[TBL] [Abstract][Full Text] [Related]
8. Daily Vibrotactile Stimulation Exhibits Equal or Greater Spasticity Relief Than Botulinum Toxin in Stroke.
Seim C; Chen B; Han C; Vacek D; Lowber A; Lansberg M; Okamura AM
Arch Phys Med Rehabil; 2023 Oct; 104(10):1565-1572. PubMed ID: 37149017
[TBL] [Abstract][Full Text] [Related]
9. Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis.
Gracies JM; Francisco GE; Jech R; Khatkova S; Rios CD; Maisonobe P;
J Neurol Phys Ther; 2021 Jul; 45(3):203-213. PubMed ID: 34039905
[TBL] [Abstract][Full Text] [Related]
10. Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US.
Hull M; Anupindi VR; DeKoven M; He J; Bouchard J
Adv Ther; 2023 Sep; 40(9):3986-4003. PubMed ID: 37414904
[TBL] [Abstract][Full Text] [Related]
11. Safety and Real-World Dosing of OnabotulinumtoxinA for the Treatment of Adult Spasticity: Post Hoc Analysis of the Adult Spasticity International Registry Study.
Bavikatte G; Esquenazi A; Dimyan MA; Dashtipour K; Feng W; Mayadev A; Fanning K; Musacchio T; Zuzek A; Francisco GE
Am J Phys Med Rehabil; 2024 Jul; 103(7):580-587. PubMed ID: 38206635
[TBL] [Abstract][Full Text] [Related]
12. Upper Limb Casting Application Post-Botulinum Toxin Injection for Elbow Spasticity: A Guided Casting Protocol.
Wortley K; Carda S; Ganzert C; Farag J; Reebye R
Am J Phys Med Rehabil; 2024 Jul; 103(7):645-649. PubMed ID: 38630558
[TBL] [Abstract][Full Text] [Related]
13. Safety of botulinum toxin injections in children less than one year old: A retrospective chart review.
Deshpande N; Gormley ME; Deshpande S
J Pediatr Rehabil Med; 2024; 17(1):67-73. PubMed ID: 37574745
[TBL] [Abstract][Full Text] [Related]
14. Clinical presentation of patients with lower limb spasticity undergoing routine treatment with botulinum toxin: baseline findings from an international observational study.
Esquenazi A; Zorowitz RD; Ashford S; Maisonobe P; Page S; Jacinto J
J Rehabil Med; 2023 Oct; 55():jrm4257. PubMed ID: 37794845
[TBL] [Abstract][Full Text] [Related]
15. Are paraspinous intramuscular injections of botulinum toxin a (BoNT-A) efficient in the treatment of chronic low-back pain? A randomised, double-blinded crossover trial.
Cogné M; Petit H; Creuzé A; Liguoro D; de Seze M
BMC Musculoskelet Disord; 2017 Nov; 18(1):454. PubMed ID: 29141611
[TBL] [Abstract][Full Text] [Related]
16. Does the method of botulinum neurotoxin injection for limb spasticity affect outcomes? A systematic review.
Chan AK; Finlayson H; Mills PB
Clin Rehabil; 2017 Jun; 31(6):713-721. PubMed ID: 27370102
[TBL] [Abstract][Full Text] [Related]
17. Treatment of spasticity in spinal cord injury with botulinum toxin.
Palazón-García R; Alcobendas-Maestro M; Esclarin-de Ruz A; Benavente-Valdepeñas AM
J Spinal Cord Med; 2019 May; 42(3):281-287. PubMed ID: 29869974
[TBL] [Abstract][Full Text] [Related]
18. AbobotulinumtoxinA: A New Therapy for Hip Osteoarthritis. A Prospective Randomized Double-Blind Multicenter Study.
Eleopra R; Rinaldo S; Lettieri C; Santamato A; Bortolotti P; Lentino C; Tamborino C; Causero A; Devigili G
Toxins (Basel); 2018 Oct; 10(11):. PubMed ID: 30384438
[No Abstract] [Full Text] [Related]
19. Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial.
Burmeister J; Holle D; Bock E; Ose C; Diener HC; Obermann M
Trials; 2015 Dec; 16():550. PubMed ID: 26634453
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of repeated injections of botulinum toxin A on gait and fatigue in adults with spastic paraparesis secondary to multiple sclerosis.
Vázquez-Doce A; Delgado LG; Arriaza Gómez MJ; Spottorno Rubio MP; Lallana VM; Muñoz BDR; Bosch-Martín MA; Doce OV; García PO; Juan NT
NeuroRehabilitation; 2024; 54(4):663-675. PubMed ID: 38875050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
